Ader P, Blöck M, Pietzsch S, Wolffram S
Institute of Animal Nutrition, Physiology and Metabolism, Christian-Albrechts-University, Olshausenstrasse 40, 24098, Kiel, Germany.
Cancer Lett. 2001 Jan 26;162(2):175-80. doi: 10.1016/s0304-3835(00)00645-5.
Recently it has been postulated that flavonoid glucosides may be absorbed by the small intestine via the SGLT-1. Therefore, we applied an in vitro mucosal uptake method to investigate mucosal uptake of the non-metabolisable glucose analogue methyl-alpha-D-glucopyranoside (MDG) as influenced by quercetin-3-glucoside (isoquercitrin) and quercetin-4'-glucoside (spiraeosid). We found that both glucosides significantly inhibited SGLT-1-mediated MDG uptake whereas the aglycon quercetin or the quercetin-3-rhamnoglucoside (rutin) were ineffective. Calculated apparent kinetic parameters (Km, Vmax) of initial Na+-dependent MDG uptake by the jejunal mucosa indicate a competitive type of inhibition.